Clinical Trials Browser

Phase 2 × NIH × apalutamide × Clear all

NCT04530552 2026-03-19

Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland

Phase 2 Active not recruiting

34 enrolled 11 charts

Prostatic Neoplasms